Qol-AF Registry: Quality of life evaluation


Qol-AF Registry: Quality of life evaluation of AFNET trials and registries


Health status war assessed for atrial fibrillation (AF) patients from the AFNET trials Gap-AF - AFNET 1, ANTIPAF - AFNET 2, Flec-SL - AFNET 3 and the central patient registry (AB1).

Coordinating Investigator

Prof. Karl-Heiz Ladwig, Munich, Germany

Overall Responsibility

Kompetenznetz Vorhofflimmern - Competence Network on Atrial Fibrillation

Current Status



German Federal Ministry of Education and Research


Von Eisenhart Rothe A, Hutt F, Baumert J, Breithardt G, Goette A, Kirchhof P, Ladwig KH. Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis-data from the German Competence Network on Atrial Fibrillation. Europace. 2015; 17:1354-62. doi: 10.1093/europace/euv018. Epub 2015 Mar 30.

Von Eisenhart Rothe A, Goette A, Kirchhof P, Breithardt G, Limbourg T, Calvert M et al. Depression in paroxysmal and persistent atrial fibrillation patients: a crosssectional comparison of patients enroled in two large clinical trials. Europace 2014; 16:812-9. doi: 10.1093/europace/eut361

Von Eisenhart Rothe A, Bielitzer M, Meinertz T, Limbourg T, Ladwig KH, Goette A. Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: Findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial. Am Heart J. 2013 Sep;166(3):589-596.e1. doi: 10.1016/j.ahj.2013.05.020.

Ladwig KH et al. How well do electrophysiologists estimate the degree of quality of life impairment of their patients with paroxysmal atrial fibrillation? Results from the ANTIPAF Trial. Europace 2013; 15 (S2): 109 (Abstract)